Latest news
Iconovo signs an agreement with Stevanato Group regarding the manufacture, sale and distribution of ICOcap
The inhalation developer Iconovo AB (publ) announced today that the company has signed an agreement with the multinational Stevanato Group, headquartered…
Dr Orest Lastow is lecturing at Dry Powder Inhalers Annual Conference London 20-21 June 2018
The second generation of DPIs have become either established on the market or are a significant way along the approval process. These have been a great…
Press releases
Jun 11, 2025, 08:30
News
IR
English
Corporate Action
Other
mfn-ext-nq
mfn-ext-nq-corporate-action
Jun 11, 2025, 08:30
News
IR
Swedish
Corporate Action
Other
mfn-ext-nq
mfn-ext-nq-corporate-action
Jun 09, 2025, 14:00
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Raport bolagsstämman
Jun 09, 2025, 08:15
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Staff change
Jun 09, 2025, 08:15
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Staff change
Jun 03, 2025, 16:42
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
mfn-ext-nq
mfn-ext-nq-listing
Jun 03, 2025, 16:42
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
mfn-ext-nq
mfn-ext-nq-listing
Jun 02, 2025, 18:50
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
mfn-ext-nq
mfn-ext-nq-company-announcement
Jun 02, 2025, 18:50
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
mfn-ext-nq
mfn-ext-nq-company-announcement
May 27, 2025, 10:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
mfn-ext-nq
mfn-ext-nq-listing
May 27, 2025, 10:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
mfn-ext-nq
mfn-ext-nq-listing
May 15, 2025, 10:30
News
IR
English
Regulatory
Listing Regulation
Corporate Action
Prospectus
mfn-cus-disclaimer
May 15, 2025, 10:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Action
Prospectus
mfn-cus-disclaimer
May 12, 2025, 13:35
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Raport bolagsstämman
May 07, 2025, 14:20
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
May 06, 2025, 18:20
News
IR
English
Correction
Regulatory
Listing Regulation
Report
Annual
May 06, 2025, 13:40
News
IR
English
Regulatory
Listing Regulation
Report
Annual
Apr 25, 2025, 08:15
News
IR
Swedish
Regulatory
Listing Regulation
Report
Annual
Apr 24, 2025, 15:00
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Nomination Committee
Apr 24, 2025, 15:00
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Nomination Committee
Possessing a unique combination
of engineering and pharma expertise, Iconovo can provide the optimal combination of customized inhalers and tailored formulations.
ICONOVO AB
VISITING ADDRESS
Ideon, Delta 6 Lund
Ideongatan 3B
POSTAL ADDRESS
Iconovo AB
Ideongatan 3A-B
SE-223 62 LUND
Sweden
CONTACT
Phone: +46 46 275 67 77
Director Business Development and Alliances
Måns Österberg
Mail: mans.osterberg@iconovo.se
CEO
Anders Månsson
Mail: anders.mansson@iconovo.se
Press releases
Follow us on Linkedin
